Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes.
作者信息
Djebbari Faouzi, Panitsas Fotios, Sharpley Faye A, Rampotas Alexandros, Larham Jemma, Moore Sally, Gooding Sarah, Kothari Jaimal, Ramasamy Karthik
机构信息
Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Department of Haematology, Laiko General Hospital, Athens, Greece.
出版信息
Eur J Haematol. 2020 Nov;105(5):662-666. doi: 10.1111/ejh.13479. Epub 2020 Jul 15.
Abstract
摘要
相似文献
1
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes.英国在新冠疫情期间骨髓瘤护理的调整：挑战与可衡量的结果
Eur J Haematol. 2020 Nov;105(5):662-666. doi: 10.1111/ejh.13479. Epub 2020 Jul 15.
2
COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan.多发性骨髓瘤患者的新型冠状病毒肺炎感染：来自维尔茨堡和武汉的德中经验
Ann Hematol. 2021 Mar;100(3):843-846. doi: 10.1007/s00277-020-04184-2. Epub 2020 Jul 18.
3
Multiple Myeloma in the Time of COVID-19.COVID-19 时期的多发性骨髓瘤。
Acta Haematol. 2020;143(5):410-416. doi: 10.1159/000507690. Epub 2020 Apr 17.
4
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK).第一波新冠疫情后的骨髓瘤临床结局：来自泰晤士河谷癌症联盟（英国）的结果
Br J Haematol. 2021 Mar;192(6):e136-e139. doi: 10.1111/bjh.17261. Epub 2020 Dec 16.
5
Management of patients with multiple myeloma during the COVID-19 pandemic.2019冠状病毒病大流行期间多发性骨髓瘤患者的管理
Lancet Haematol. 2020 Jun;7(6):e435-e437. doi: 10.1016/S2352-3026(20)30124-1. Epub 2020 Apr 27.
6
Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis.浆细胞骨髓瘤合并AL淀粉样变性过程中的腹水
Turk J Haematol. 2018 Mar 1;35(1):71-72. doi: 10.4274/tjh.2016.0262. Epub 2016 Aug 16.
7
Tandem bone marrow transplantation in multiple myeloma.多发性骨髓瘤的串联骨髓移植
N Engl J Med. 2004 Apr 1;350(14):1466-7; author reply 1466-7.
8
Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management.多发性骨髓瘤：2018 年诊断、风险分层和治疗更新。
Am J Hematol. 2018 Aug 16;93(8):981-1114. doi: 10.1002/ajh.25117.
9
Daratumumab for the treatment of AL amyloidosis.达雷妥尤单抗治疗淀粉样变性。
Leuk Lymphoma. 2019 Feb;60(2):295-301. doi: 10.1080/10428194.2018.1485914. Epub 2018 Jul 22.
10
Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in a Patient with Concomitant Porphyria Cutanea Tarda.自体干细胞移植治疗伴迟发性皮肤卟啉症患者的多发性骨髓瘤
Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):e264-e266. doi: 10.1016/j.clml.2020.12.004. Epub 2020 Dec 11.
引用本文的文献
1
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.延迟诊断导致多发性骨髓瘤疾病负担增加：COVID-19 大流行的后果。
Blood Cancer J. 2023 Mar 15;13(1):38. doi: 10.1038/s41408-023-00795-w.
本文引用的文献
1
Cancer and COVID-19: what do we really know?癌症与2019冠状病毒病：我们究竟了解什么？
Lancet. 2020 Jun 20;395(10241):1884-1885. doi: 10.1016/S0140-6736(20)31240-X. Epub 2020 May 29.
2
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.接受化疗或其他抗癌治疗的癌症患者的 COVID-19 死亡率：一项前瞻性队列研究。
Lancet. 2020 Jun 20;395(10241):1919-1926. doi: 10.1016/S0140-6736(20)31173-9. Epub 2020 May 28.
3
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN).COVID-19 大流行时代多发性骨髓瘤患者的管理：来自欧洲骨髓瘤网络（EMN）的共识文件。
Leukemia. 2020 Aug;34(8):2000-2011. doi: 10.1038/s41375-020-0876-z. Epub 2020 May 22.
4
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.接受全身抗癌治疗的多发性骨髓瘤患者感染严重急性呼吸综合征冠状病毒（COVID-19疾病）出现症状后的临床影响的真实世界评估。
Br J Haematol. 2020 Jul;190(2):e83-e86. doi: 10.1111/bjh.16874. Epub 2020 Jun 10.
5
Care of haematology patients in a COVID-19 epidemic.2019冠状病毒病疫情期间血液科患者的护理
Br J Haematol. 2020 Apr;189(2):241-243. doi: 10.1111/bjh.16620. Epub 2020 Mar 15.
6
Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience.卡非佐米治疗复发骨髓瘤：英国多中心经验结果
Br J Haematol. 2020 Feb;188(4):e57-e60. doi: 10.1111/bjh.16324. Epub 2019 Dec 2.
7
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.免疫球蛋白轻链淀粉样变性：2018 年诊断、预后和治疗更新。
Am J Hematol. 2018 Sep;93(9):1169-1180. doi: 10.1002/ajh.25149.
8
Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.曾接受治疗的多发性骨髓瘤治疗方法的疗效比较：系统文献回顾和网络荟萃分析。
Clin Ther. 2018 Mar;40(3):480-494.e23. doi: 10.1016/j.clinthera.2018.01.014. Epub 2018 Feb 28.
9
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.来那度胺联合地塞米松治疗不适合移植的骨髓瘤患者。
N Engl J Med. 2014 Sep 4;371(10):906-17. doi: 10.1056/NEJMoa1402551.
10
Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value.染色体 1q21 获得在硼替佐米治疗多发性骨髓瘤中预后不良，但拷贝数变异和受累浆细胞比例无额外预后价值。
Haematologica. 2014 Feb;99(2):353-9. doi: 10.3324/haematol.2013.088211. Epub 2013 Nov 8.
Zotero 插件